Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Sign Up to like & getrecommendations! Published in 2020 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000003869
Abstract: Up to 12 months of elagolix with add-back therapy provided sustained reduction in menstrual blood loss with an acceptable safety profile in women with uterine leiomyomas. read more here.
Keywords: women heavy; uterine leiomyomas; elagolix treatment; heavy menstrual ... See more keywords
Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "BMC Women's Health"
DOI: 10.1186/s12905-022-01596-2
Abstract: Background Elagolix is effective and safe for treating menorrhagia in women with uterine fibroid. However, it is reported to be associated with hypoestrogenism that can be alleviated by adding estradiol/norethindrone acetate. This systematic review and… read more here.
Keywords: elagolix; elagolix treatment; norethindrone acetate; heavy menstrual ... See more keywords